A Rapid and Quantitative Serum Test for SARS-CoV-2 Antibodies with Portable Surface Plasmon Resonance Sensing

We report a surface plasmon resonance (SPR) sensor detecting nucleocapsid antibodies specific against the novel coronavirus 2019 (SARS-CoV-2) in undiluted human serum. When exposed to SARS-CoV-2, the immune system responds by expressing antibodies at levels that can be detected and monitored to identify the patient population immunized against SARD-CoV-2 and support efforts to deploy a vaccine strategically. A SPR sensor coated with a peptide monolayer and functionalized with SARS-CoV-2 nucleocapsid recombinant protein detected anti-SARS-CoV-2 antibodies in the nanomolar range. This bioassay was performed on a portable SPR instrument in undiluted human serum and results were collected within 15 minutes of sample/sensor contact. This strategy paves the way to point-of-care and label-free rapid testing for antibodies..

Medienart:

Preprint

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

chemRxiv.org - (2021) vom: 17. Nov. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

Djaileb, Abdelhadi [VerfasserIn]
Charron, Benjamin [VerfasserIn]
Jodaylami, Maryam Hojjat [VerfasserIn]
Thibault, Vincent [VerfasserIn]
Coutu, Julien [VerfasserIn]
Stevenson, Keisean [VerfasserIn]
Forest, Simon [VerfasserIn]
Live, Ludovic S. [VerfasserIn]
Boudreau, Denis [VerfasserIn]
Pelletier, Joelle N. [VerfasserIn]
Masson, Jean-Francois [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

540
Chemistry

doi:

10.26434/chemrxiv.12118914

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XCH017604796